One Client at a Time

Unparalleled staff to patient ratio of 15:1

resurgence of interest in the therapeutic use

Over the past few decades, there has been a resurgence of interest in the therapeutic use of psychedelics. Researchers are uncovering promising results in treating various conditions, from depression and anxiety to addiction and PTSD.

Psychedelic substances like psilocybin, LSD, and MDMA have long been associated with counterculture and illicit drug use. However, recent studies have demonstrated their potential as powerful tools for healing and personal growth. Through carefully guided sessions with trained therapists, individuals have reported transformative experiences that have helped them break free from negative thought patterns, overcome trauma, and improve their overall quality of life.


Paracelsus Recovery is one of the few high-end European-based treatment centres supporting the psychedelic revolution. We are legally permitted to provide ketamine-assisted psychotherapy at our centre in Zurich, Switzerland. However, we hope to offer other psychedelic treatment options as soon as legalisation permits. In the meantime, we are active and involved in various ways:

I. Public Speaking Events

FT Weekend: All you wanted to know about psychedelics...

... but were afraid to ask.

Once demonised, ketamine, LSD and psilocybin are now used to treat everything from PTSD to depression. Are they working? Moderated by Beatrice Hodgkin, deputy editor, HTSI, the conference will include insights from our founder, Jan Gerber, along with Neil Markey, Beckley Retreats and Matthew W. Johnson, professor of psychiatry and behavioural sciences, Johns Hopkins. 




The REACH at The Kennedy Centre, Online & On Demand

Saturday, May 20, 12.00 PM – 12.45 PM EDT.

Jan Gerber is the founder and CEO of Swiss Clinics Group and Paracelsus Recovery, a specialist clinic providing state-of-the-art mental health and addiction treatment to high-profile international clientele in Zurich and London. He holds an MSc in Finance from the London School of Economics. After a few years in the consulting industry, he founded several companies in the healthcare sector, including several clinics. He also holds several board seats. Jan is a frequent speaker on mental health awareness, particularly on the intersection of mental health and wealth, as well as state-of-the-art, experimental and complementary approaches to mental health treatments.

Jan A. Gerber, founder and CEO of Swiss Clinics Group and Paracelsus Recovery

Financial Times Weekend Life Streaming

As soon as the conference starts, you will find the lifestreaming video here.



Latest Articles

Ayahuasca Treatment: Can a Psychedelic Plant Have Therapeutic Benefits?

Will Psychedelic Drugs Revolutionise Psychiatric Treatment?

Which Drugs are Leading the Psychedelic Revolution?

Treatment Programmes

Ketamine-Assisted Therapy for Treatment-Resistant Depression

Ketamine-Assisted Therapy at Paracelsus Recovery